Utilization and Spending on Fixed-Dose Combination Treatment for Hypertension in Medicare and Medicaid, 2016-2020

被引：0
|
作者：
Essa, Mohammed
Ross, Joseph S.
Dhruva, Sanket
Desai, Nihar R.
Spatz, Erica S.
Faridi, Kamil
机构：
来源：
CIRCULATION | 2023年 / 148卷
关键词：
Hypertension; Antihypertensive agents; Elderly; Population science; Epidemiology;
D O I：
10.1161/circ.148.suppl_1.13591
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
A13591
引用
收藏
页数：2
相关论文
共 50 条
  • [41] FIXED-DOSE COMBINATIONS IN THE TREATMENT OF HYPERTENSION IN THE RUSSIAN FEDERATION
    Vladimir, Kutsenko
    Balanova, Yulia
    Shalnova, Svetlana
    Imaeva, Asiia
    Kapustina, Anna
    Muromtseva, Galina
    Evstifeeva, Svetlana
    Karamnova, Natalya
    Maksimov, Sergey
    Yarovaya, Elena
    JOURNAL OF HYPERTENSION, 2021, 39 : E245 - E245
  • [42] An equivalence study of the safety and efficacy of a fixed-dose combination of perindopril with indapamide versus fixed-dose combinations of captopril with hydrochlorothiazide and enalapril with hydrochlorothiazide in the treatment of hypertension
    Luccioni, R
    Sever, PS
    DiPerri, T
    Redon, J
    Laurandin, I
    Brault, Y
    Chastang, C
    Guez, D
    Andrejak, M
    Araud, JM
    Aupy, JM
    Baclet, JL
    Baixas, JP
    Baud, J
    Billaut, P
    Bin, E
    Bioulac, B
    Blanche, M
    Blondel, D
    Bogetto, D
    Bonneau, D
    Bontemps, P
    Boucher, L
    Bourneuf, P
    Bouvet, P
    Boye, A
    Cabot, JM
    Cahoreau, R
    Calmet, G
    Campard, JC
    Cases, B
    Cassin, H
    Castellani, J
    Clerson, P
    Cognee, F
    CollRotger, J
    Constensoux, JP
    Copere, C
    Cozic, JA
    Dahan, G
    DalleRive, MC
    deSainteLorette, E
    Deltour, LC
    Drugeon, M
    Dubourg, D
    Dupont, S
    Cirica, NE
    ElSawy, A
    Eoche, R
    Etchegaray, G
    JOURNAL OF HYPERTENSION, 1995, 13 (12) : 1847 - 1851
  • [43] Availability and utilization of cardiovascular fixed-dose combination drugs in the United States
    Wang, Bo
    Choudhry, Niteesh K.
    Gagne, Joshua J.
    Landon, Joan
    Kesselheint, Aaron S.
    AMERICAN HEART JOURNAL, 2015, 169 (03) : 379 - 386
  • [44] Netarsudil/latanoprost fixed-dose combination for the treatment of open-angle glaucoma or ocular hypertension
    Radell, J. E.
    Serle, J. B.
    DRUGS OF TODAY, 2019, 55 (09) : 563 - 574
  • [45] Cost minimization analysis of combination therapy in the treatment of hypertension: fixed-dose vs extemporary combinations
    Bellone, Marco
    Sbarra, Pierluigi
    FARMECONOMIA-HEALTH ECONOMICS AND THERAPEUTIC PATHWAYS, 2013, 14 (04) : 153 - 160
  • [46] Fixed-dose combination therapy in pulmonary arterial hypertension: Pros & cons
    Manzi, Giovanna
    Recchioni, Tommaso
    Badagliacca, Roberto
    Papa, Silvia
    Vizza, Carmine Dario
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2024, 406
  • [47] Study examines economic impact of fixed-dose combination therapies for hypertension
    Jackson, JH
    Farrelly, EW
    FORMULARY, 2002, 37 (10) : 539 - 540
  • [48] CLINICAL-EXPERIENCE WITH A FIXED-DOSE COMBINATION OF PENBUTOLOL AND FUROSEMIDE IN HYPERTENSION
    KNOBEN, JMAM
    CHADHA, DR
    CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 1982, 31 (03): : 281 - 292
  • [49] Is the fixed-dose combination of telmisartan and hydrochlorothiazide a good approach to treat hypertension?
    Maillard, Marc P.
    Burnier, Michel
    VASCULAR HEALTH AND RISK MANAGEMENT, 2007, 3 (03) : 265 - 278
  • [50] Amlodipine/valsartan fixed-dose combination: a guide to its use in hypertension
    Drugs & Therapy Perspectives, 2008, 24 (8) : 5 - 8
12345